These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

61 related articles for article (PubMed ID: 3667353)

  • 21. Delayed-type hypersensitivity to heparin with tolerance of its intravenous administration.
    Irion R; Gall H; Peter RU
    Contact Dermatitis; 2000 Oct; 43(4):249-50. PubMed ID: 11011948
    [No Abstract]   [Full Text] [Related]  

  • 22. [Skin necrosis related to subcutaneous heparin administration. Heparin necrosis].
    Berkessy S; Tuka P; Radványi G; Balyi G; Pauker Z; Somogyi E; Takács I
    Orv Hetil; 1981 Dec; 122(50):3075-80. PubMed ID: 7329684
    [No Abstract]   [Full Text] [Related]  

  • 23. Utility of thrombocytopenia as a marker for heparin allergy in adult ED patients.
    Howell MD; Powers RD
    Am J Emerg Med; 2006 May; 24(3):268-70. PubMed ID: 16635695
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Heparin allergy: delayed-type non-IgE-mediated allergic hypersensitivity to subcutaneous heparin injection.
    Trautmann A; Seitz CS
    Immunol Allergy Clin North Am; 2009 Aug; 29(3):469-80. PubMed ID: 19563992
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Bullous hemorrhagic dermatosis occurring at sites distant from subcutaneous injections of heparin: three cases.
    Perrinaud A; Jacobi D; Machet MC; Grodet C; Gruel Y; Machet L
    J Am Acad Dermatol; 2006 Feb; 54(2 Suppl):S5-7. PubMed ID: 16427995
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The efficacy and safety of perioperative low molecular weight heparin substitution in patients on chronic oral anticoagulant therapy undergoing transurethral prostatectomy for bladder outlet obstruction.
    Dotan ZA; Mor Y; Leibovitch I; Varon D; Golomb J; Duvdevani M; Ramon J
    J Urol; 2002 Aug; 168(2):610-3; discussion 614. PubMed ID: 12131319
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Thrombocytopenia induced by low-dose subcutaneous heparin.
    Hrushesky W
    Lancet; 1977 Dec; 2(8051):1286. PubMed ID: 73980
    [No Abstract]   [Full Text] [Related]  

  • 28. [Subcutaneous calcium heparinate: a new heparin].
    Desrochers Y
    Union Med Can; 1975 May; 104(5):722-8. PubMed ID: 1136066
    [No Abstract]   [Full Text] [Related]  

  • 29. Thrombocytopenia induced by low-dose subcutaneous heparin.
    Malcolm ID; Wigmore TA
    Lancet; 1978 Feb; 1(8061):444. PubMed ID: 75470
    [No Abstract]   [Full Text] [Related]  

  • 30. [Subcutaneous calcifications: a rare side effect of calcium heparin].
    Tumiati B; Azzarito C; lo Scocco G; Veneziani M; Bertani A
    Medicina (Firenze); 1988; 8(3):322-3. PubMed ID: 3231046
    [No Abstract]   [Full Text] [Related]  

  • 31. Low-dose subcutaneous heparin therapy.
    Sharnoff JG
    N Y State J Med; 1990 Jan; 90(1):39. PubMed ID: 2296393
    [No Abstract]   [Full Text] [Related]  

  • 32. Eosinophilic panniculitis after subcutaneous administration of sodium heparin.
    Batalla A; Rosón E; Posada C; Flórez A
    Indian J Dermatol Venereol Leprol; 2013; 79(6):849. PubMed ID: 24177633
    [No Abstract]   [Full Text] [Related]  

  • 33. Administration of sub-cutaneous (sub-cu) heparin.
    Mikulaninec C
    J Vasc Nurs; 1990 Dec; 8(4):23. PubMed ID: 2265105
    [No Abstract]   [Full Text] [Related]  

  • 34. Hypereosinophilia and subcutaneous heparin.
    Giustolisi R; Guglielmo P; di Raimondo F; Cacciola E; Stagno F
    Lancet; 1993 Nov; 342(8883):1371. PubMed ID: 7901670
    [No Abstract]   [Full Text] [Related]  

  • 35. [A new method of heparin therapy: subcutaneous administration... even in pediatric indications!].
    Marosvári I; Nagy Z
    Orv Hetil; 1989 Jun; 130(25):1359. PubMed ID: 2748154
    [No Abstract]   [Full Text] [Related]  

  • 36. Surreptitious self-administration of heparin.
    Martin CM; Engstrom PF; Barrett O
    JAMA; 1970 Apr; 212(3):475-6. PubMed ID: 5467299
    [No Abstract]   [Full Text] [Related]  

  • 37. Factors to consider before discontinuing heparin in patients who develop thrombocytopenia.
    Shalansky SJ; Verma AK; Levine M
    Pharmacotherapy; 1999 Aug; 19(8):1011-2. PubMed ID: 10453976
    [No Abstract]   [Full Text] [Related]  

  • 38. Comparison at the clinical level of different types and routes of heparin administration.
    Bouvier CA
    Scand J Haematol Suppl; 1980; 36():91-100. PubMed ID: 6935764
    [No Abstract]   [Full Text] [Related]  

  • 39. Heparin-induced skin reaction.
    Ulrick PJ; Manoharan A
    Med J Aust; 1984 Mar; 140(5):287-9. PubMed ID: 6700462
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Generalized reaction to subcutaneous heparin.
    Patrizi A; Di Lernia V; Patrone P
    Contact Dermatitis; 1989 Apr; 20(4):309-10. PubMed ID: 2752744
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.